![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MA Blackshear and E Sanders-Bush
The chronic administration of mianserin for 14 days leads to a marked decrease in the maximal number of serotonin2 (5-HT2) binding sites in brains of rats and mice with no change in the KD values. The decrease in [3H]spiroperidol binding to the 5-HT2 site in rats was most pronounced in the frontal cortex with only minor changes in hippocampus and pons-medulla. The 5-HT1 site was largely unaffected. The decrease in the Bmax for 5-HT2 site also occurred after a single dose of mianserin, although mianserin was more potent when given chronically. Maximal inhibition of binding occurred with a chronic dose of 0.5 mg/kg. The greatest decrease was found 48 hr after single or repeated doses with a gradual return to normal levels within 10 days. The administration of mianserin also leads to a decrease in 5-methoxy-N,N- dimethyltryptamine-induced head twitches in mice assayed 48 and 96 hr after a single or repeated doses, which is presumably correlated with the decrease in the 5-HT2 binding site assayed in vitro.
This article has been cited by other articles:
|
|
 |
|
  K. D. Dave, J. A. Harvey, and V. J. Aloyo The Time-Course for Up- and Down-Regulation of the Cortical 5-Hydroxytryptamine (5-HT)2A Receptor Density Predicts 5-HT2A Receptor-Mediated Behavior in the Rabbit J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 327 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Costa, L. Steardo, and V. Cuomo Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects Pharmacol. Rev., March 1, 2004; 56(1): 103 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. S. Hanley and J. G. Hensler Mechanisms of Ligand-Induced Desensitization of the 5-Hydroxytryptamine2A Receptor J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 468 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Aloyo, K. D. Dave, T. Rahman, and J. A. Harvey Selective and Divergent Regulation of Cortical 5-HT2A Receptors in Rabbit J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1066 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. N. YATHAM, P. F. LIDDLE, I-S. SHIAH, R. W. LAM, M. J. ADAM, A. P. ZIS, and T. J. RUTH Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study The British Journal of Psychiatry, May 1, 2001; 178(5): 448 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. N. Yatham, P. F. Liddle, I-S. Shiah, G. Scarrow, R. W. Lam, M. J. Adam, A. P. Zis, and T. J. Ruth Brain Serotonin2 Receptors in Major Depression: A Positron Emission Tomography Study Arch Gen Psychiatry, September 1, 2000; 57(9): 850 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Yatham, P. F. Liddle, J. Dennie, I-S. Shiah, M. J. Adam, C. J. Lane, R. W. Lam, and T. J. Ruth Decrease in Brain Serotonin 2 Receptor Binding in Patients With Major Depression Following Desipramine Treatment: A Positron Emission Tomography Study With Fluorine-18-Labeled Setoperone Arch Gen Psychiatry, August 1, 1999; 56(8): 705 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sibille, Z. Sarnyai, D. Benjamin, J. Gal, H. Baker, and M. Toth Antisense Inhibition of 5-Hydroxytryptamine2a Receptor Induces an Antidepressant-Like Effect in Mice Mol. Pharmacol., December 1, 1997; 52(6): 1056 - 1063. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Delini-Stula and E. Mogilnicka Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers J Psychopharmacol, January 1, 1989; 3(1): 7 - 13. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
